Related Experiment Video
Updated: Jan 8, 2026

11:21
Integrated Photoacoustic Ophthalmoscopy and Spectral-domain Optical Coherence Tomography
Published on: January 15, 2013
11.9K
Industry-Reported Financial Relationships Among American Ophthalmology Society Board Members
Mostafa Bondok1, Leonardo Lando2, Anne Xuan-Lan Nguyen3
1Section of Ophthalmology, Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Clinical & Experimental Ophthalmology
|December 14, 2025
Summary
Financial disclosures for American ophthalmology board members are rarely public, despite industry payments. Societies should improve transparency in conflict of interest (COI) reporting for better governance.
Area of Science:
- Ophthalmology
- Medical Ethics
- Health Policy
Background:
- Financial relationships between industry and ophthalmology society board members are common.
- Assessing the transparency of these financial disclosures is crucial for ethical governance.
Purpose of the Study:
- To compare self-reported financial disclosures with industry-reported payments for American ophthalmology society board members.
- To identify characteristics associated with significant financial relationships.
Main Methods:
- Retrospective, cross-sectional study of 871 board members from 66 American ophthalmology societies in December 2022.
- Data sources included society websites, Open Payments database, and IRS Form 990 filings.
- Analysis focused on disclosure concordance, payment values, gender, subspecialty, and academic factors.
Main Results:
- Only 2.5% of board members disclosed conflicts of interest (COIs) on society websites, despite 65.0% having industry-reported relationships totaling $57.8 million in 2022.
- Men received significantly higher median payments than women ($217.5 vs. $43.3).
- Retina specialists received the largest payment share (55.3%), while those with research payments showed higher academic productivity.
Conclusions:
- Public reporting of board members' financial relationships on ophthalmology society websites is uncommon.
- This likely reflects varied society-level disclosure practices rather than individual nondisclosure.
- Societies have an opportunity to enhance transparency through consistent COI reporting.
Related Concept Videos
Open Angle Glaucoma: Treatment
928
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
928
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

